{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:11:06Z","timestamp":1777900266131,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T00:00:00Z","timestamp":1205971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2407-8-77","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T18:14:05Z","timestamp":1207073645000},"source":"Crossref","is-referenced-by-count":52,"title":["Plasma MMP1 and MMP8 expression in breast cancer: Protective role of MMP8 against lymph node metastasis"],"prefix":"10.1186","volume":"8","author":[{"given":"Julie","family":"Decock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Hendrickx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Vanleeuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanya","family":"Van Belle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Van Huffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Rose","family":"Christiaens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Paridaens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,20]]},"reference":[{"key":"1015_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/annonc\/mdl498","volume":"18","author":"J Ferlay","year":"2007","unstructured":"Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007, 18: 581-592. 10.1093\/annonc\/mdl498.","journal-title":"Ann Oncol"},{"key":"1015_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/sj.bjc.6602794","volume":"93","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Wessels LF, Bosma AJ, Glas AM, Nuyten DS, He YD, Dai H, Peterse JL, van't Veer LJ: No common denominator for breast cancer lymph node metastasis. Br J Cancer. 2005, 93: 924-932. 10.1038\/sj.bjc.6602794.","journal-title":"Br J Cancer"},{"key":"1015_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002, 2: 161-174. 10.1038\/nrc745.","journal-title":"Nat Rev Cancer"},{"key":"1015_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina EI, Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006, 25: 9-34. 10.1007\/s10555-006-7886-9.","journal-title":"Cancer Metastasis Rev"},{"key":"1015_CR5","first-page":"348","volume":"54","author":"U Coskun","year":"2007","unstructured":"Coskun U, Yamac D, Gulbahar O, Sancak B, Karaman N, Ozkan S: Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?. Neoplasma. 2007, 54: 348-352.","journal-title":"Neoplasma"},{"key":"1015_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/1097-0215(20000720)89:4<389::AID-IJC12>3.0.CO;2-J","volume":"89","author":"E Farias","year":"2000","unstructured":"Farias E, Ranuncolo S, Cresta C, Specterman S, Armanasco E, Varela M, Lastiri J, Pallotta MG, Bal De Kier JE, Puricelli L: Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer. 2000, 89: 389-394. 10.1002\/1097-0215(20000720)89:4<389::AID-IJC12>3.0.CO;2-J.","journal-title":"Int J Cancer"},{"key":"1015_CR7","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/sj.bjc.6601725","volume":"90","author":"G La Rocca","year":"2004","unstructured":"La Rocca G, Pucci-Minafra I, Marrazzo A, Taormina P, Minafra S: Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer. 2004, 90: 1414-1421. 10.1038\/sj.bjc.6601725.","journal-title":"Br J Cancer"},{"key":"1015_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1158\/1078-0432.CCR-03-0047","volume":"10","author":"S Leppa","year":"2004","unstructured":"Leppa S, Saarto T, Vehmanen L, Blomqvist C, Elomaa I: A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res. 2004, 10: 1057-1063. 10.1158\/1078-0432.CCR-03-0047.","journal-title":"Clin Cancer Res"},{"key":"1015_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cca.2006.02.026","volume":"371","author":"SC Liu","year":"2006","unstructured":"Liu SC, Yang SF, Yeh KT, Yeh CM, Chiou HL, Lee CY, Chou MC, Hsieh YS: Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clin Chim Acta. 2006, 371: 92-96. 10.1016\/j.cca.2006.02.026.","journal-title":"Clin Chim Acta"},{"key":"1015_CR10","first-page":"3593","volume":"27","author":"M Quaranta","year":"2007","unstructured":"Quaranta M, Daniele A, Coviello M, Venneri MT, Abbate I, Caringella ME, Di TS, Divella R, Trerotoli P, Di GM, Schittulli F, Fransvea E, Giannelli G: MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res. 2007, 27: 3593-3600.","journal-title":"Anticancer Res"},{"key":"1015_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/ijc.11288","volume":"106","author":"SM Ranuncolo","year":"2003","unstructured":"Ranuncolo SM, Armanasco E, Cresta C, Bal De Kier JE, Puricelli L: Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients. Int J Cancer. 2003, 106: 745-751. 10.1002\/ijc.11288.","journal-title":"Int J Cancer"},{"key":"1015_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0304-3835(01)00657-7","volume":"173","author":"SM Sheen-Chen","year":"2001","unstructured":"Sheen-Chen SM, Chen HS, Eng HL, Sheen CC, Chen WJ: Serum levels of matrix metalloproteinase 2 in patients with breast cancer. Cancer Lett. 2001, 173: 79-82. 10.1016\/S0304-3835(01)00657-7.","journal-title":"Cancer Lett"},{"key":"1015_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canlet.2004.06.056","volume":"217","author":"A Talvensaari-Mattila","year":"2005","unstructured":"Talvensaari-Mattila A, Turpeenniemi-Hujanen T: Preoperative serum MMP-9 immunoreactive protein is a prognostic indicator for relapse-free survival in breast carcinoma. Cancer Lett. 2005, 217: 237-242. 10.1016\/j.canlet.2004.06.056.","journal-title":"Cancer Lett"},{"key":"1015_CR14","first-page":"140","volume":"53","author":"S Zucker","year":"1993","unstructured":"Zucker S, Lysik RM, Zarrabi MH, Moll U: M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 1993, 53: 140-146.","journal-title":"Cancer Res"},{"key":"1015_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1749-6632.1999.tb07687.x","volume":"878","author":"S Zucker","year":"1999","unstructured":"Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L, Boyd D, Nicolson G, Montana S: Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci. 1999, 878: 212-227. 10.1111\/j.1749-6632.1999.tb07687.x.","journal-title":"Ann N Y Acad Sci"},{"key":"1015_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.biochi.2004.12.009","volume":"87","author":"R Ala-aho","year":"2005","unstructured":"Ala-aho R, Kahari VM: Collagenases in cancer. Biochimie. 2005, 87: 273-286. 10.1016\/j.biochi.2004.12.009.","journal-title":"Biochimie"},{"key":"1015_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000098072","volume":"78","author":"FO Rodriguez","year":"2007","unstructured":"Rodriguez FO, Fernandez Gomez JM, Palou RJ, Escaf BS, Vizoso F, Villavicencio MH: Significance of collagenase 3 (matrix metalloproteinase 13) in invasive bladder cancer: correlation with pathological parameters. Urol Int. 2007, 78: 140-144. 10.1159\/000098072.","journal-title":"Urol Int"},{"key":"1015_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cytogfr.2006.04.001","volume":"17","author":"P Van Lint","year":"2006","unstructured":"Van Lint P, Libert C: Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 2006, 17: 217-223. 10.1016\/j.cytogfr.2006.04.001.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1015_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ijc.22652","volume":"121","author":"F Mannello","year":"2007","unstructured":"Mannello F, Tonti GA: Gelatinase concentrations and zymographic profiles in human breast cancer: matrix metalloproteinases circulating in plasma are better markers for the subclassification and early prediction of cancer: the coagulation\/fibrinolysis pathways alter the release, activation and recovery of different gelatinases in serum. Int J Cancer. 2007, 121: 216-218. 10.1002\/ijc.22652.","journal-title":"Int J Cancer"},{"key":"1015_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1634\/theoncologist.12-8-904","volume":"12","author":"AM Gonzalez-Angulo","year":"2007","unstructured":"Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobagyi GN: Trends for inflammatory breast cancer: is survival improving?. Oncologist. 2007, 12: 904-912. 10.1634\/theoncologist.12-8-904.","journal-title":"Oncologist"},{"key":"1015_CR21","doi-asserted-by":"crossref","first-page":"25742","DOI":"10.1016\/S0021-9258(18)47310-3","volume":"269","author":"JL Fowlkes","year":"1994","unstructured":"Fowlkes JL, Enghild JJ, Suzuki K, Nagase H: Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem. 1994, 269: 25742-25746.","journal-title":"J Biol Chem"},{"key":"1015_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1046\/j.1432-0436.2003.710202.x","volume":"71","author":"D Agarwal","year":"2003","unstructured":"Agarwal D, Goodison S, Nicholson B, Tarin D, Urquidi V: Expression of matrix metalloproteinase 8 (MMP-8) and tyrosinase-related protein-1 (TYRP-1) correlates with the absence of metastasis in an isogenic human breast cancer model. Differentiation. 2003, 71: 114-125. 10.1046\/j.1432-0436.2003.710202.x.","journal-title":"Differentiation"},{"key":"1015_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ng1249","volume":"35","author":"M Balbin","year":"2003","unstructured":"Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD, Lopez-Otin C: Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet. 2003, 35: 252-257. 10.1038\/ng1249.","journal-title":"Nat Genet"},{"key":"1015_CR24","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1158\/0008-5472.CAN-03-2047","volume":"64","author":"V Montel","year":"2004","unstructured":"Montel V, Kleeman J, Agarwal D, Spinella D, Kawai K, Tarin D: Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res. 2004, 64: 1687-1694. 10.1158\/0008-5472.CAN-03-2047.","journal-title":"Cancer Res"},{"key":"1015_CR25","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.1158\/0008-5472.CAN-07-1683","volume":"67","author":"J Decock","year":"2007","unstructured":"Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, Pearce EG, Gao YT, Pereira AC, Paridaens R, Zheng W, Ye S: Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res. 2007, 67: 10214-10221. 10.1158\/0008-5472.CAN-07-1683.","journal-title":"Cancer Res"},{"key":"1015_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/path.1078","volume":"197","author":"M Moilanen","year":"2002","unstructured":"Moilanen M, Pirila E, Grenman R, Sorsa T, Salo T: Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas. J Pathol. 2002, 197: 72-81. 10.1002\/path.1078.","journal-title":"J Pathol"},{"key":"1015_CR27","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.ejca.2003.08.011","volume":"39","author":"S Stadlmann","year":"2003","unstructured":"Stadlmann S, Pollheimer J, Moser PL, Raggi A, Amberger A, Margreiter R, Offner FA, Mikuz G, Dirnhofer S, Moch H: Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer. Eur J Cancer. 2003, 39: 2499-2505. 10.1016\/j.ejca.2003.08.011.","journal-title":"Eur J Cancer"},{"key":"1015_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000070655","volume":"24","author":"M Stenman","year":"2003","unstructured":"Stenman M, Paju A, Hanemaaijer R, Tervahartiala T, Leminen A, Stenman UH, Konttinen YT, Sorsa T: Collagenases (MMP-1, -8 and -13) and trypsinogen-2 in fluid from benign and malignant ovarian cysts. Tumour Biol. 2003, 24: 9-12. 10.1159\/000070655.","journal-title":"Tumour Biol"},{"key":"1015_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc1821","volume":"6","author":"CM Overall","year":"2006","unstructured":"Overall CM, Kleifeld O: Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer. 2006, 6: 227-239. 10.1038\/nrc1821.","journal-title":"Nat Rev Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-77\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:19:19Z","timestamp":1630973959000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-77","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,20]]},"article-number":"77"}}